|
Volumn 48, Issue 3, 2015, Pages 357-359
|
The benefits and potential drawbacks in the approval of EVZIO for lay reversal of opioid overdose
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ADRENALIN;
NALOXONE;
OPIATE;
PRESCRIPTION DRUG;
NARCOTIC AGENT;
NARCOTIC ANTAGONIST;
ALGORITHM;
ARTICLE;
DRUG APPROVAL;
DRUG COST;
DRUG INTOXICATION;
DRUG MARKETING;
DRUG MONITORING;
DRUG OVERDOSE;
EMERGENCY HEALTH SERVICE;
EVIDENCE BASED PRACTICE;
FOOD AND DRUG ADMINISTRATION;
HEALTH CARE ACCESS;
HIGH RISK POPULATION;
OPIOID OVERDOSE;
PATENT;
PRESCRIPTION;
RISK ASSESSMENT;
SUPPORT GROUP;
ECONOMICS;
HUMAN;
UNITED STATES;
DRUG APPROVAL;
DRUG OVERDOSE;
HUMANS;
NALOXONE;
NARCOTIC ANTAGONISTS;
NARCOTICS;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
EID: 84926176953
PISSN: 07493797
EISSN: 18732607
Source Type: Journal
DOI: 10.1016/j.amepre.2014.09.011 Document Type: Review |
Times cited : (4)
|
References (10)
|